Dymon Asia Capital (Singapore)’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,000	Closed	-$428K	–	67
2024 Q2	$428K	Sell	3,000 -5,000	-63%	-$714K	0.11%	30
2024 Q1	$1.03M	Buy	+8,000	New	+$1.03M	0.23%	20